[go: up one dir, main page]

AU2002347778A1 - Enzymes - Google Patents

Enzymes

Info

Publication number
AU2002347778A1
AU2002347778A1 AU2002347778A AU2002347778A AU2002347778A1 AU 2002347778 A1 AU2002347778 A1 AU 2002347778A1 AU 2002347778 A AU2002347778 A AU 2002347778A AU 2002347778 A AU2002347778 A AU 2002347778A AU 2002347778 A1 AU2002347778 A1 AU 2002347778A1
Authority
AU
Australia
Prior art keywords
enzymes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002347778A
Inventor
Mariah R. Baughn
Shanya D. Becha
Umesh Bhatia
Julie J. Blake
John D. Burrill
Hsin-Ru Chang
Narinder K. Chawla
Brendan M. Duggan
Vicki S. Elliott
Brooke M. Emerling
Ian J. Forsythe
Jing Gao
Ann E. Gorvad
Jennifer A. Griffin
April J.A. Hafalia
Anne Ho
Craig H. Ison
Alan A. Jackson
Xin Jiang
Pei Jin
Amy E. Kable
Preeti G. Lal
Ernestine A. Lee
Sally Lee
Soo Yeun Lee
Joana X. Li
Dyung Aina M. Lu
Joseph P. Marquis
Jayalaxmi Ramkumar
Thomas W. Richardson
Anita Swarnakar
Y. Tom Tang
Uyen K. Tran
Bridget A. Warren
Amy D. Wilson
Junming Yang
Monique G. Yao
Henry Yue
Yeganeh Zebarjadian
Wenjin Zheng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2002347778A1 publication Critical patent/AU2002347778A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)
    • C12N9/20Triglyceride splitting, e.g. by means of lipase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
AU2002347778A 2001-09-28 2002-09-26 Enzymes Abandoned AU2002347778A1 (en)

Applications Claiming Priority (25)

Application Number Priority Date Filing Date Title
US32638801P 2001-09-28 2001-09-28
US60/326,388 2001-09-28
US32897901P 2001-10-12 2001-10-12
US60/328,979 2001-10-12
US34603401P 2001-10-19 2001-10-19
US60/346,034 2001-10-19
US34828401P 2001-10-26 2001-10-26
US60/348,284 2001-10-26
US33804801P 2001-11-08 2001-11-08
US60/338,048 2001-11-08
US33234001P 2001-11-16 2001-11-16
US60/332,340 2001-11-16
US34035701P 2001-12-14 2001-12-14
US60/340,357 2001-12-14
US36872202P 2002-03-29 2002-03-29
US36879902P 2002-03-29 2002-03-29
US60/368,722 2002-03-29
US60/368,799 2002-03-29
US38155802P 2002-05-17 2002-05-17
US60/381,588 2002-05-17
US38711902P 2002-06-07 2002-06-07
US60/387,119 2002-06-07
US39066202P 2002-06-21 2002-06-21
US60/390,662 2002-06-21
PCT/US2002/031096 WO2003042357A2 (en) 2001-09-28 2002-09-26 Enzymes

Publications (1)

Publication Number Publication Date
AU2002347778A1 true AU2002347778A1 (en) 2003-05-26

Family

ID=27583841

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002347778A Abandoned AU2002347778A1 (en) 2001-09-28 2002-09-26 Enzymes

Country Status (5)

Country Link
EP (1) EP1434860A2 (en)
JP (1) JP2005525788A (en)
AU (1) AU2002347778A1 (en)
CA (1) CA2460959A1 (en)
WO (1) WO2003042357A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005076012A2 (en) * 2004-01-30 2005-08-18 Five Prime Therapeutics, Inc. Novel splice variants and methods of use thereof
DE602004019215D1 (en) * 2004-10-02 2009-03-12 Immatics Biotechnologies Gmbh Immunogenic T-helper epitopes of human tumor antigens and their use in immunotherapeutic methods
AU2006216683A1 (en) * 2005-02-24 2006-08-31 Cemines, Inc. Compositions and methods for classifying biological samples
US20100216703A1 (en) * 2006-08-14 2010-08-26 The Regents Of The University Of California Inhibitors of PDE4 and Methods of Use
BR112013005872A2 (en) 2010-09-22 2019-09-24 Alios Biopharma Inc compounds, pharmaceutical composition and their uses
CA2860234A1 (en) 2011-12-22 2013-06-27 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
US8916538B2 (en) 2012-03-21 2014-12-23 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
HK1203356A1 (en) 2012-03-22 2015-10-30 艾丽奥斯生物制药有限公司 Pharmaceutical combinations comprising a thionucleotide analog
JP6529960B2 (en) * 2014-03-21 2019-06-12 池田食研株式会社 Flavin-bound glucose dehydrogenase
WO2018069430A1 (en) * 2016-10-13 2018-04-19 bioMérieux Identification and antibiotic characterization of pathogens in metagenomic sample
CN110749687B (en) * 2019-04-04 2021-05-28 中山大学 A urine biomarker for early diagnosis of schistosomiasis japonica and its screening method and application
CN116083379B (en) * 2023-01-18 2024-09-27 安徽华恒生物科技股份有限公司 Transporter variant and application thereof in R-pantoic acid preparation

Also Published As

Publication number Publication date
WO2003042357A3 (en) 2003-11-20
JP2005525788A (en) 2005-09-02
CA2460959A1 (en) 2003-05-22
EP1434860A2 (en) 2004-07-07
WO2003042357A2 (en) 2003-05-22

Similar Documents

Publication Publication Date Title
AU2002357860A1 (en) Enzymes
AU2002337489A1 (en) Inexsufflator
AU2003238930A1 (en) Enzymes
AU2002347778A1 (en) Enzymes
AU2002319532A1 (en) Feeding-bottles
AU2002353397A1 (en) Mini-kraftformer
AU2003245747A1 (en) Enzymes
AU2003216376A1 (en) Enzymes
AU2002257273A1 (en) Enzymes
AU2003225282A1 (en) Enzymes
AU2003220607A1 (en) Enzymes
AU2002313943A1 (en) Electromobile
AU2002236595A1 (en) Enzymes
AUPR482001A0 (en) Metal-handling enzymes
AU2002226571A1 (en) Biligands
AU2002330790A1 (en) Ferro-sticker
AU2003294219A1 (en) Enzymes
AU2002257925A1 (en) Numberplates
AU2002100746A4 (en) Adrail
AU2001100214A4 (en) Dolly-trolley
AU2001100532A4 (en) FonePark
AU2001100522A4 (en) e-Trans
AU2002300980A1 (en) Insanityse
AU2002253687A1 (en) Floss-pick
AU2002305440A1 (en) Piperazinyl-isatins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase